Streptococcus agalactiae

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instance_of gptkb:physicist
gptkbp:bfsLayer 5
gptkbp:bfsParent gptkb:Streptococci
gptkbp:caused_by Group B streptococcal disease
gptkbp:communication vertical transmission
https://www.w3.org/2000/01/rdf-schema#label Streptococcus agalactiae
gptkbp:is_associated_with gptkb:healthcare_organization
meningitis
sepsis
skin infections
urinary tract infections
neonatal infections
chorioamnionitis
postpartum infections
gptkbp:is_found_in gptkb:Person
gastrointestinal tract
vaginal flora
gptkbp:is_monitored_by gptkb:CDC
gptkb:WHO
gptkbp:is_often_used_in pregnant women
gptkbp:is_part_of gptkb:municipality
public health initiatives
human microbiome
normal flora
infectious disease control
Lancefield group B
gptkbp:is_protected_by intrapartum antibiotic prophylaxis
gptkbp:is_recognized_by neonatal screening
PCR testing
culture methods
pregnant women screening
gptkbp:is_related_to gptkb:Streptococcus_pyogenes
gptkb:Streptococcus_pneumoniae
gptkbp:is_studied_in antibiotic resistance
microbiology
epidemiology
infectious diseases
vaccine development
pathogenesis
gptkbp:is_vulnerable_to macrolides
gptkbp:scientific_classification Gram-positive
coccus
gptkbp:sensor gptkb:penicillin
gptkbp:symptoms fever
irritability
difficulty breathing
lethargy
poor feeding
gptkbp:treatment gptkb:ampicillin
antibiotics
vancomycin
clindamycin